Literature DB >> 4359678

Virus excretion in smallpox. 1. Excretion in the throat, urine, and conjunctiva of patients.

J K Sarkar, A C Mitra, M K Mukherjee, S K De, D G Mazumdar.   

Abstract

Excretion of virus in the throat, urine, and conjunctiva of smallpox patients was studied daily for 2-3 weeks after the onset of fever. The virus titre in the throat and urine of haemorrhagic and confluent cases was higher than in discrete cases. The duration of virus excretion was also greater in confluent cases than in discrete cases. Conjunctival swabs from all 12 smallpox patients with conjunctivitis were positive for virus. The duration and titre of virus excretion in the throat, urine, and conjunctiva of patients were not related to their age or sex and did not depend on whether or not they had received a primary vaccination.

Entities:  

Mesh:

Year:  1973        PMID: 4359678      PMCID: PMC2482928     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  5 in total

1.  Conjunctivitis and subclinical infection in smallpox.

Authors:  C H Kempe; F Dekking; L Saint Vincent; A R Rao; A W Downie
Journal:  J Hyg (Lond)       Date:  1969-12

2.  Viraemia in haemorrhagic and other forms of smallpox.

Authors:  A C Mitra; S N Chatterjee; J K Sarkar; P Manji; A K Das
Journal:  J Indian Med Assoc       Date:  1966-08-01

3.  Epidemiological studies in smallpox. A study of intrafamilial transmission in a series of 254 infected families.

Authors:  A R Rao; E S Jacob; S Kamalakshi; S Appaswamy
Journal:  Indian J Med Res       Date:  1968-12       Impact factor: 2.375

4.  An airborne outbreak of smallpox in a German hospital and its significance with respect to other recent outbreaks in Europe.

Authors:  P F Wehrle; J Posch; K H Richter; D A Henderson
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

5.  Virulence of variola virus isolated from smallpox cases of varying severity.

Authors:  J K Sarkar; A C Mitra
Journal:  Indian J Med Res       Date:  1967-01       Impact factor: 2.375

  5 in total
  17 in total

1.  The minimum protective level of antibodies in smallpox.

Authors:  J K Sarkar; A C Mitra; M K Mukherjee
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

2.  Detection of smallpox virus DNA by LightCycler PCR.

Authors:  Mark J Espy; Franklin R Cockerill III; Richard F Meyer; Michael D Bowen; Gregory A Poland; Ted L Hadfield; Thomas F Smith
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

Review 3.  Infectiousness of smallpox relative to disease age: estimates based on transmission network and incubation period.

Authors:  H Nishiura; M Eichner
Journal:  Epidemiol Infect       Date:  2006-12-07       Impact factor: 2.451

4.  Evaluation of the precipitation-in-gel reaction in the diagnosis of smallpox.

Authors:  A C Mitra; J K Sarkar; M K Mukherjee; M S Chakravarty
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

5.  Obligatory requirement for antibody in recovery from a primary poxvirus infection.

Authors:  Geeta Chaudhri; Vijay Panchanathan; Horst Bluethmann; Gunasegaran Karupiah
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

6.  Virus excretion in smallpox. 2. Excretion in the throats of household contacts.

Authors:  J K Sarkar; A C Mitra; M K Mukherjee; S K De
Journal:  Bull World Health Organ       Date:  1973-05       Impact factor: 9.408

7.  Virus content of smallpox scabs.

Authors:  A C Mitra; J K Sarkar; M K Mukherjee
Journal:  Bull World Health Organ       Date:  1974       Impact factor: 9.408

Review 8.  Antibody therapeutics for Ebola virus disease.

Authors:  Larry Zeitlin; Kevin J Whaley; Gene G Olinger; Michael Jacobs; Robin Gopal; Xiangguo Qiu; Gary P Kobinger
Journal:  Curr Opin Virol       Date:  2016-01-27       Impact factor: 7.090

Review 9.  What was the primary mode of smallpox transmission? Implications for biodefense.

Authors:  Donald K Milton
Journal:  Front Cell Infect Microbiol       Date:  2012-11-29       Impact factor: 5.293

10.  ST-246 inhibits in vivo poxvirus dissemination, virus shedding, and systemic disease manifestation.

Authors:  Aklile Berhanu; David S King; Stacie Mosier; Robert Jordan; Kevin F Jones; Dennis E Hruby; Douglas W Grosenbach
Journal:  Antimicrob Agents Chemother       Date:  2009-09-14       Impact factor: 5.938

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.